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The absorbed doses deposited by boron neutron capture therapy (BNCT) can be categorized into four compo-
nents: α and 7Li particles from the 10B(n, α)7Li reaction, 0.54-MeV protons from the 14N(n, p)14C reaction,
the recoiled protons from the 1H(n, n) 1H reaction, and photons from the neutron beam and 1H(n, γ)2H reac-
tion. For evaluating the irradiation effect in tumors and the surrounding normal tissues in BNCT, it is of great
importance to estimate the relative biological effectiveness (RBE) for each dose component in the same frame-
work. We have, therefore, established a new method for estimating the RBE of all BNCT dose components on
the basis of the microdosimetric kinetic model. This method employs the probability density of lineal energy, y,
in a subcellular structure as the index for expressing RBE, which can be calculated using the microdosimetric
function implemented in the particle transport simulation code (PHITS). The accuracy of this method was tested
by comparing the calculated RBE values with corresponding measured data in a water phantom irradiated with
an epithermal neutron beam. The calculation technique developed in this study will be useful for biological dose
estimation in treatment planning for BNCT.
Keywords: boron neutron capture therapy; microdosimetry; PHITS; RBE
INTRODUCTION
Boron neutron capture therapy (BNCT) is a binary treatment
modality that was advocated by Locher in 1936 and that can
selectively target tumor tissues [1]. The two particles (an α
particle and a lithium (7Li) particle) generated in the neutron
capture reaction with boron) have high linear energy transfer
(LET) and a short range (of the order of one cell diameter).
In principle, BNCT allows the preferential destruction of
10B-loaded tumor cells, sparing normal tissues without 10B.
The radiation field of BNCT produced in normal tissues
and tumors consists of a mixture of several particles, such as
neutrons, protons, photons, α particles and 7Li particles. In
the estimation of the physical dose, these particles are cate-
gorized into four major dose components [2]: α particles and
7Li particles from the 10B(n, α)7Li reaction, 0.54-MeV
protons from the 14N(n, p)14C reaction, the recoiled protons
from the 1H(n, n) 1H reaction, and photons from the neutron
beam and 1H(n, γ)2H reaction; these dose components are
called the boron, nitrogen, hydrogen and gamma doses, re-
spectively, in this paper. The boron dose from the neutron
capture reaction accounts for the majority of the biological
effect in tumor tissues [3]. The other dose components
deliver background doses (from a mixture of high- and
low-LET radiation components) to both normal and tumor
tissues [4].
In order to estimate the treatment effect, the physical dose
needs to be converted to the biological dose. Therefore, each
of the four major dose components is multiplied by their
relative biological effectiveness (RBE), which is determined
on the basis of certain endpoints of clinical or experimental
irradiation conditions. The RBE of each dose component
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depends on the variation in the physical dose according to
the dose dependence of the cell survival curves. In addition,
the RBE of the recoiled proton component depends on the
variation in the spectral characteristics of the neutron beam.
Therefore, it is necessary to evaluate the biological dose by
taking into account the dependence not only on the dose, but
also on the neutron spectrum. These dependencies are not
currently considered in treatment planning for BNCT.
Hence, development of a biological dose estimation model
that can take these dependencies into account is needed.
A number of studies based on models that use a microdosi-
metric cellular scale have been devoted to the evaluation of
the biological effectiveness of BNCT. For example, Bond
et al. and Gabel et al. proposed the use of a ‘hit size effect-
iveness function’ (HSEF) that gives a cell survival fraction as
a function of the energy deposition in a cell nucleus [5, 6].
The HSEF was implemented in the microdosimetry model
developed by Vliet-Vroegindeweij et al., which can calculate
the cell survival fraction of all the important high-LET radi-
ation components for BNCT [7]. Santa Cruz et al. developed
a model for estimating the biological dose for BNCT, taking
into account the synergistic interactions between different
radiations [8, 9]. However, none of the existing models can
express the RBE of each of the four major BNCT dose com-
ponents in the same framework. We have, therefore, devel-
oped a calculation method for estimating the biological dose
for each of the four major BNCT dose components. This
method is based on the microdosimetric kinetic (MK) model
[10], which was derived from the theory of dual radiation
action [11]. The MK model can calculate the cell survival
fractions of various charged particles from the probability
density of specific energy in a conceptual subcellular (submi-
cron) structure of the cell nucleus (called a ‘domain’). The
MK model is adapted to the treatment planning for heavy
charged-particle therapy in the Heavy-ion Medical
Accelerator in Chiba [12, 13].
In this study, the RBEs of each of the four major dose
components were estimated using the MK model. For this
purpose, it was necessary to calculate the microscopic prob-
ability density of lineal energy, y, in a macroscopic matter. In
our method, the probability density of y in the domain was
calculated using the microdosimetric function [14] imple-
mented in the macroscopic particle transport simulation code
(PHITS) [15]. Detailed procedures based on the MK model
for estimating the RBE of each of the four major BNCT dose
components are presented herein, together with the results of
their verification using a past biological experiment for V79
Chinese hamster cells [16, 17].
MATERIALS ANDMETHODS
RBE calculation by the MKmodel
Using the MK model, the cell survival fractions of various
charged particles can be estimated from the probability
densities of specific energies in the domain. The procedures
based on the MK model for estimating the cell survival frac-
tion and RBE for each of the four major BNCT dose compo-
nents are provided in this section.
According to the linear–quadratic (LQ) model, the cell
survival fraction can be expressed as follows:
S ¼ expðaD bD2Þ; ð1Þ
where S is the survival fraction for the absorbed dose, D. The
parameters α and β are the linear coefficient and quadratic
coefficient of LQ parameters, respectively. The RBE of
various charged particles for the cell survival fraction, S, is
calculated as follows:
RBEðSÞ ¼ DgðSÞ
DðSÞ
¼
ag þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a2g  4bglnðSÞ
q
2bg
aþ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃa2  4blnðSÞp
2b
;
ð2Þ
where Dγ(S) and D(S) are the absorbed dose for a reference
radiation and a radiation of interest, respectively, for the
similar value of the survival fraction, S. Note that the γ-rays
emitted from the 137Cs source are regarded as the reference
radiation for estimating the RBE in this study. The para-
meters αγ and βγ are the LQ parameters that can be experi-
mentally obtained from the survival curve of cells irradiated
by γ-rays. Thus, the RBEs of any radiation can be estimated
by determining their LQ parameters, α and β. The β param-
eter for each cell can be mathematically derived as a constant
in the MK model [10], and its numerical value can be
obtained from the survival curve of the cells irradiated by a
reference radiation. In the Kase-proposed MK model, the
parameter α can be estimated from the obtained β as follows
[18, 19]:
a ¼ a0 þ bz1D; ð3Þ
where α0 is a constant that represents the initial slope of the
survival fraction curve in the limit of LET = 0. The parameter
z1D denotes the saturation-corrected dose-mean specific
energy defined in ICRU Report 36 [20], which can be calcu-
lated as follows:
z1D ¼
l
m
y
¼ 1
rpr2d
y20
ð1
0
1 exp½ðy=y0Þ2
y
dðy; 2rdÞdy;
ð4Þ
where l, m, ρ and rd are the mean chord length, mass, density
and radius of the domain, and d(y, 2rd) is the absorbed-dose
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probability density of y for site diameter 2rd. The parameter
y* is the saturation-corrected dose-mean lineal energy, and
y0 is a so-called saturation parameter that indicates the lineal
energy above which correction for the saturation due to the
overkill effect becomes very important.
If one can determine ρ, rd, α0, y0 and β, the linear coeffi-
cient of α for any radiation field can be estimated by calculat-
ing d(y, 2rd) in the field. Thus, preceding the calculation of
the survival fraction using the MK model, these five para-
meters should be determined. The domain density ρ can be
assumed to be 1.0 g/cm3. The parameter β can be obtained
from the survival curve irradiated by a source of reference ra-
diation, such as γ-rays, as mentioned before. The other three
parameters rd, α0 and y0 can be determined by substituting
the experimentally obtained α parameters for various radi-
ation fields and their d(y, 2rd) values into Eqs. (3) and (4),
respectively.
In this study, the parameter β and the other three para-
meters rd, α0 and y0 for V79 Chinese hamster cells were
determined from a past experiment that was performed to
measure their cell survival fractions with γ-rays and a
neutron beam, respectively. The d(y, 2rd) was calculated
using the microdosimetric function in the PHITS code [14].
The details are described below.
Estimation of cell survival fraction for the free-air
experiment
To determine the MK model parameters, we estimated the α
parameter for the boron, proton and gamma doses by re-
evaluating a past experiment measuring the cell survival frac-
tion of V79 Chinese hamster cells incubated with boric acid
of 0, 5 and 10 ppm 10B concentrations irradiated with γ-rays
from a 137Cs source and an epithermal neutron beam in the
Japan Research Reactor No. 4 (JRR-4) [17]. Boric acid
serves as a reference boron carrier for the boron dose compo-
nent because it is assumed that this compound distributes
boron atoms uniformly throughout the cell, nucleus and ex-
ternal compartment [21,22]. The biological response of the
boron dose component cannot be directly determined from
the measured data. To estimate the survival fraction of the
boron dose component, we compared the irradiation
responses of boronated cells with those of non-boronated
cells. The biological responses of protons from nitrogen
capture reactions and hydrogen recoils cannot be experimen-
tally distinguished, because they are attributed to protons
emitted from the natural composition of the cell nucleus (i.e.
unlike the attribution from boron, which is artificially added
to the cells). This dose component is termed the ‘proton
dose’ in this report. The cell survival fraction of the proton
dose component was estimated by comparing cell survival
fractions for non-boronated cells irradiated with neutron
beams with those irradiated with γ-rays.
The β term in the LQ model can be ignored for the limit of
D = 0, when the parameter α is higher than β. Then, the
survival fraction can be simply approximated as follows:
s ¼ expðaDÞ; ð5Þ
where s is the survival fraction for only the very low-dose ir-
radiation. Figure 1 shows the survival curves of V79 Chinese
hamster cells directly irradiated by the JRR-4 neutron beam;
this direct irradiation is called a ‘free-air experiment’, in con-
trast to a ‘phantom experiment’, in which cells are irradiated
in a water phantom, as described later.
The survival fraction of the boron dose component is
expressed as the ratio of the survival fractions with and
without boron. For very low-dose irradiation, the survival
fraction of the boron dose component, sB, can be written as
follows:
sB ¼ swtBswoB
¼ expðawtBDwtBÞ
expðawoBDwoBÞ
¼ expðaBDBÞ;
ð6Þ
where swtB and swoB are the survival fractions of boronated
and non-boronated cells, respectively. αwtB and αwoB are α
parameters for boronated and non-boronated cells, respect-
ively, and αB is the α parameter for the boron dose only. The
absorbed dose for boronated cells, DwtB, is expressed as
the sum of the boron dose component, DB, and the dose for
non-boronated cells, DwoB; i.e.:
DwtB ¼ DB þ DwoB: ð7Þ
Fig. 1. Survival curves for irradiation of V79 Chinese hamster
cells with γ-rays and with the epithermal neutron beam in the JRR-4
incubated with boric acid of 0, 5 and 10 ppm 10B concentrations.
The data were plotted as a function of the absorbed dose and were
fitted by LQ equations.
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From Eqs. (6) and (7), αB is expressed as follows:
aB ¼ awtB 1þ DwoBDB
 
 awoB DwoBDB : ð8Þ
Therefore, the α parameter of the boron dose component, αB,
is calculated using the value of DwoB/DB, and αwtB and
αwoB obtained from the survival curves of V79 Chinese
hamster cells. The dose components DB and DwoB are
expressed as follows:
DB ¼ KB;thf thCB and ð9Þ
DwoB ¼ DN þ DH þ Dg; ð10Þ
where KB,th is the neutron kerma factor for the boron dose
component, for which the numerical value is evaluated to be
7.51  10−14 Gy·cm2/ppm [23], φth is the thermal neutron
fluence measured by gold foils, and CB is the
10B concentra-
tion in the conditioned medium in parts per million. DN, DH
and Dγ are the nitrogen, hydrogen and gamma dose compo-
nents, respectively. DwoB is expressed as the sum of the non-
boron dose components. Each dose component DN and DH is
estimated as follows:
DN ¼ KN;thfth and ð11Þ
DH ¼ KH;thfth; ð12Þ
where KN,th is the neutron kerma factor for the nitrogen dose
component, for which the numerical value was evaluated to
be 1.50  10−13 Gy·cm2 [23]. KH,th is the special kerma
factor that converts thermal neutron flux to the hydrogen
dose; this value depends on the neutron spectrum, and its nu-
merical value for the JRR-4 epithermal neutron beam was
evaluated to be 4.03  10−13 Gy·cm2 [23]. The gamma dose
was measured using a thermoluminescent dosimeter (TLD)
that had beryllium oxide as a thermoluminescence material
and was covered with quartz glass (Panasonic 170LS).
According to Eq. (1), the survival fraction of the boron
dose component for a wide dose range, SB, can be expressed
as follows:
SB ¼ expðaBDB  bD2BÞ; ð13Þ
where αB can be determined by Eq. (8), and β can be
obtained from the survival curves of γ-ray irradiations.
Similar to Eq. (8), the α parameter of the proton dose, αp,
for low-dose irradiation is expressed as follows:
ap ¼ awoB 1þ DgDp
 
 agDgDp ; ð14Þ
where Dp is the absorbed dose for the proton dose expressed
as the sum of the nitrogen dose component and the hydrogen
dose component.
Determination of MKmodel parameters
Probability densities of the lineal energy in microscopic sites
cannot be directly calculated from the conventional particle
transport simulation of the Particle and Heavy Ion Transport
code System (PHITS), since it is designed to simulate par-
ticle motions on a macroscopic scale and employs a
continuous-slowing-down approximation for calculating the
energy loss of charged particles. Therefore, a special tally
function was introduced into the code for calculating the
microdosimetric probability densities (using a mathematical
function that can instantaneously calculate quantities around
trajectories of charged particles). The function was devel-
oped on the basis of track structure simulation, taking into
account the productions of δ-rays and Auger electrons [14,
24]. Using this function, we can calculate the probability
densities of y for all types of charged particles and target
sizes with a precision equivalent to that of the microscopic
track-structure simulation.
In our calculation, the probability densities of the depos-
ited energy in water target sites for the boron, nitrogen,
hydrogen and gamma doses were calculated separately using
the sources defined as follows:
(i) The source of the boron dose was defined as a
multiple source, taking into account the branching
ratio and initial energies of released particles, i.e.
1.47-MeV α particles and 0.84-MeV Li particles
in 93.7% of the events, and 1.78-MeV α particles
and 1.01-MeV Li particles in 6.3% of the events.
(ii) The source of the nitrogen dose was defined as
monoenergetic protons with an initial energy of
0.54 MeV.
(iii) The sources of the hydrogen doses were defined
as protons for which the energy spectra were the
same as those of protons generated in a test tube
filled with water and a tissue-equivalent material
[25] with a diameter of 4 cm, respectively, irra-
diated by the epithermal neutron beam in the
JRR-4. Here, tissue composition was assumed to
be: H (10.1%), C (11.1%), N (2.6%) and O
(76.2%) by weight percentage.
(iv) The source of the gamma dose was defined as
monoenergetic photons with an initial energy of
0.662 MeV.
The parameters necessary in the MK model for estimating
the cell survival fraction are β, rd, α0 and y0. The parameter β
can be obtained from the survival curve of γ-ray irradiations.
The other three parameters, rd, α0 and y0, can be estimated
from the least-square fittings of all the experimental data for
the free-air condition. These fittings were performed: (i) to
calculate the d(y, 2rd) for the boron, proton and gamma
doses from the PHITS code using the temporary rd value;
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(ii) to estimate the α0 and y0 from the least-square fittings of
all the experimental data based on Eqs. (3) and (4); (iii) to
update the rd value as the minimum condition of the error for
the α parameter between the measured and calculated values;
and (iv) to go back to procedure (1) until the values of the
three parameters were converged.
RBE estimation in a water phantom
To validate the applicability of our method for estimating the
biological dose of BNCT, we estimated the RBE of the boro-
nated and non-boronated cells in a water phantom irradiated
by the epithermal neutron beam in the JRR-4. A schematic
setup for the phantom experiment is illustrated in Fig. 2. The
RBE can be estimated by substituting α values calculated
using the MK model parameters (obtained from the free-air
experiment) into Eq. (2). The estimation of y* at the cell
locations in the phantom was calculated by performing the
PHITS simulation using the microdosimetric function. The
accuracy of this method was tested by comparing the calcu-
lated survival fraction and RBE with the corresponding ex-
perimental data obtained by Yamamoto et al. [16].
RESULTS
α value for the free-air experiment
The survival curves for the absorbed dose under free-air con-
ditions both with and without boron are also shown in Fig. 1.
The LQ parameters for the γ-ray radiations were determined
to be 0.115 ± 0.004 Gy−1 and 0.0220 ± 0.0004 Gy−2 for αγ
and β, respectively. The numerical value of αwoB was esti-
mated to be 0.626 ± 0.018 Gy−1, and that of αwtB was esti-
mated to be 0.779 ± 0.024 Gy−1 and 0.895 ± 0.054 Gy−1 for
boron concentrations of 5 ppm and 10 ppm, respectively.
The value of DwoB/DB obtained was 2.86 and 1.43 for 5 ppm
and 10 ppm, respectively. By substituting these parameters
into Eq. (8), αB was calculated to be 1.214 ± 0.105 Gy
−1 and
1.281 ± 0.133 Gy−1 for 5 ppm and 10 ppm, respectively.
However, the αB should be independent of the
10B concen-
tration, and thus we adopted the average value, 1.247 Gy−1,
in the following analysis. The parameters αwoB and αγ were
estimated to be 0.626 ± 0.018 Gy−1 and 0.115 ± 0.004 Gy−1,
respectively. The value of Dγ/Dp obtained was 0.94. By sub-
stituting these parameters into Eq. (14), αp was calculated to
be 1.106 ± 0.035 Gy−1.
Figure 3 illustrates the comparison of the cell survival frac-
tion for the boron and proton dose components estimated
from the α value obtained by re-evaluation of the past experi-
mental results using the method described above with our
simulation using LQ parameters obtained from the MK
model.
Determination of MKmodel parameters
Figure 4 shows the calculated result of the absorbed dose
probability densities, d(y, 2rd), for the boron, nitrogen,
hydrogen and proton doses. The numerical value of rd was
set to 0.222 μm. It was found from the graph that the direct
and δ-ray contributions could be clearly observed in the
higher and lower y values, respectively, for the boron dose.
The d(y, 2rd) spectrum for the hydrogen dose shifted to
lower y events than that for the nitrogen dose because of the
higher energy deposition by recoil protons.
The parameters necessary in the MK model for estimating
the cell survival fraction are β, rd, α0 and y0. The evaluated
values for β, rd, α0 and y0 were 0.022 Gy
−1, 0.222 μm, 0.052
Gy−1 and 120 keV/ μm, respectively, in this study.
Fig. 2. Schematic illustration of the irradiation setup of the water
phantom. A container plate with cell suspensions was set on the
central axis of the neutron beam. The water phantom, which
consisted of PMMA filled with water, was cylindrical and had a
diameter of 186 mm and a length of 240 mm. The diameter of the
beam aperture was 150 mm.
Fig. 3. Comparison between the cell survival fraction for boron
and proton dose components estimated from the α values obtained
by re-evaluating the past experimental results and our simulation
using LQ parameters from the MK model.
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Figure 5 shows measured α values for the boron, neutron
and gamma doses as a function of calculated y*. The rela-
tionship between α and y* resulting from Eq. (3) is also
revealed in this figure. It is evident from the graph that the
calculated α value of the boron and proton doses agrees with
the corresponding measured data very well. The agreement
for proton dose demonstrates that the α parameters for the ni-
trogen and hydrogen doses can be estimated from calculated
y*, and their α values are estimated to be 1.21 Gy−1 and 0.91
Gy−1, respectively.
RBE in a water phantom
Figure 6a illustrates the calculated and measured [26]
thermal neutron fluxes for the incidence of the epithermal
neutron beam to the phantom. The statistical uncertainties of
the calculated data were <1%. The calculated data were nor-
malized to reproduce the maximum value of the measured
thermal neutron flux. These distributions agreed with one
another within 5%, indicating the accuracy of dose calcula-
tion by the PHITS code.
Figure 6b illustrates the calculated absorbed dose for each
dose component. The boron doses were estimated by setting
the boron concentration at 5 ppm. The calculated data were
normalized by the same scaling factor used in panel (a). The
gamma dose made the dominant contribution to the total
dose in this calculated condition, because the boron concen-
tration (5 ppm) was lower than that used in the practical situ-
ation of BNCT.
Figures 7 and 8 illustrate the comparison between the mea-
sured and calculated survival fractions and RBEs of V79
Chinese hamster cells for the boronated and non-boronated
cells as a function of depth in the water phantom. Panel (a)
represents the data for cells with 5 ppm 10B concentration,
whereas Panel (b) represents the data for the non-boronated
cells. The RBEs shown in Fig. 8 were determined as end-
points corresponding to the survival fractions of the same
positions indicated in Fig. 7.
Fig. 4. Probability densities of lineal energy, d(y), for the boron,
nitrogen, hydrogen and proton doses calculated using the
microdosimetric function in the PHITS code.
Fig. 5. Measured α value for each of the four major BNCT dose
components as a function of calculated y*. The solid line and open
markers denote the relationship between α and y* expected from
Eq. (3).
Fig. 6. Measured and calculated thermal neutron flux for the
incidence of the epithermal neutron beam to the phantom (a), and
the calculated contributions from each of the four dose components
at a reactor power of 2 MW for 18 min irradiation (b).
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DISCUSSION
Cell survival fractions for the free-air experiment
The survival curves of boron and proton doses estimated
from the MK model using the obtained parameters are
shown in Fig. 3. It is evident from the graphs that the calcu-
lated data for both the boron and proton doses agree fairly
well with the corresponding measured data. These agree-
ments indicate that the cell survival fraction for the free-air
experiment of each dose component can be simply estimated
from y* calculated using the MK model.
Boron carrier
Boric acid served as a reference boron carrier for the boron dose
component because it is assumed that this compound distributes
boron atoms uniformly throughout the cell, nucleus and exter-
nal compartment [21, 22]. In this study, the RBE of the boron
dose component is estimated on the basis of this assumption.
The biological effects strongly depend on the localization
of the boron compound because of the short range of the α
and Li particles generated in the neutron capture reaction in
boron [6]. Therefore, more accurate characterization of the
microscopic distribution of the boron compounds and the
ability to consider heterogeneous distributions are required.
In our model, the approach would be applicable only for
compounds that are homogenously distributed throughout
the irradiated volume. Therefore, further studies are required
to estimate the biological effect, taking into account the
microscopic distribution of the boron compounds (e.g.
p-boronophenylalanine or sodium borocaptate).
RBE estimation in a water phantom
As can be seen in Figs, 7 and 8, survival fractions and RBEs
for various depths in the phantom can be simply estimated
from the PHITS simulation coupled with the MK model,
whose parameters are determined from the free-air experi-
ment. It is evident from the graphs that the calculated data for
both the boronated and non-boronated cells agree fairly well
Fig. 7. Comparison of the measured and calculated survival
fractions of V79 Chinese hamster cells in the water phantom
irradiated by the epithermal neutron beam. Panel (a) represents the
data for cells with 5 ppm 10B concentration, whereas Panel (b)
represents the data for the non-boronated cells.
Fig. 8. Comparison of the measured and calculated RBEs as an
endpoint corresponding to the survival fractions of the V79 Chinese
hamster cells in the water phantom irradiated by the epithermal
neutron beam (depicted in Fig. 7). Panel (a) represents the data for
cells with 5 ppm 10B concentration, whereas Panel (b) represents
the data for the non-boronated cells.
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with the corresponding measured data. However, the discrep-
ancies found at positions deeper than 40 mm in Fig. 7a and
at both less than 15 mm and deeper than 40 mm in Fig. 8a
are probably attributable to experimental uncertainty and the
difference between measured and calculated conditions, such
as the neutron spectrum in the phantom.
The depth dependences of these data are predominantly at-
tributable to the depth–dose characteristics for the each dose
component in the water phantom. In addition, the cell sur-
vival fraction and RBE for the hydrogen dose component
depends not only on the dose but also on the spectral charac-
teristics of recoiled protons (attributable to variation in the
neutron spectrum with depth in the phantom).
We have established a new method based on the MK model
for estimating the cell survival fraction or RBE for all BNCT
dose components simply from y* calculated using the PHITS
code. The RBE values can be determined by taking into
account the dependence not only on the dose but also on the
neutron spectrum. Using this method, the biological dose can
be estimated from the RBE multiplied by the physical dose,
which is also calculated using the PHITS code. An advantage
of applying this method to treatment planning for BNCT is
that it can calculate the required physical dose and RBE for
the BNCT dose components in the same framework.
Before using the model practically in treatment planning
for BNCT, further studies are required to estimate the bio-
logical effect while taking into account the localization of the
boron compound in the target cells [6, 8, 27]. It is also neces-
sary to consider the stochastic nature of absorbed doses, not
only for the domain but also for the cell nucleus, which is an
important concept in high-LET and hypofractionated radi-
ation therapy [28].
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